146 related articles for article (PubMed ID: 33760946)
21. A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma.
Kavalieris L; O'Sullivan PJ; Suttie JM; Pownall BK; Gilling PJ; Chemasle C; Darling DG
BMC Urol; 2015 Mar; 15():23. PubMed ID: 25888331
[TBL] [Abstract][Full Text] [Related]
22. Gross haematuria among adult Nigerians: current trend.
Ogunjimi MA; Adetayo FO; Tijani KH; Jeje EA; Ogo CN; Osegbe DN
Niger Postgrad Med J; 2011 Mar; 18(1):30-3. PubMed ID: 21445110
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of microscopic hematuria and risk of urologic cancer in female patients.
Lippmann QK; Slezak JM; Menefee SA; Ng CK; Whitcomb EL; Loo RK
Am J Obstet Gynecol; 2017 Feb; 216(2):146.e1-146.e7. PubMed ID: 27751797
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.
Nilbert M; Bläckberg M; Ceberg J; Hagberg O; Stenhoff R; Liedberg F
Scand J Urol; 2018 Aug; 52(4):237-243. PubMed ID: 30411661
[TBL] [Abstract][Full Text] [Related]
25. Clinical study of asymptomatic microscopic haematuria.
Yasumasu T; Koikawa Y; Uozumi J; Ueda T; Kumazawa J
Int Urol Nephrol; 1994; 26(1):1-6. PubMed ID: 8026914
[TBL] [Abstract][Full Text] [Related]
26. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria.
Loo RK; Lieberman SF; Slezak JM; Landa HM; Mariani AJ; Nicolaisen G; Aspera AM; Jacobsen SJ
Mayo Clin Proc; 2013 Feb; 88(2):129-38. PubMed ID: 23312369
[TBL] [Abstract][Full Text] [Related]
27. The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer - a multicentre observational study.
Khadhouri S; Gallagher KM; MacKenzie KR; Shah TT; Gao C; Moore S; Zimmermann EF; Edison E; Jefferies M; Nambiar A; Mannas MP; Lee T; Marra G; Lillaz B; Gómez Rivas J; Olivier J; Assmus MA; Uçar T; Claps F; Boltri M; Burnhope T; Nkwam N; Tanasescu G; Boxall NE; Downey AP; Lal AA; Antón-Juanilla M; Clarke H; Lau DHW; Gillams K; Crockett M; Nielsen M; Takwoingi Y; Chuchu N; O'Rourke J; MacLennan G; McGrath JS; Kasivisvanathan V;
BJU Int; 2021 Oct; 128(4):440-450. PubMed ID: 33991045
[TBL] [Abstract][Full Text] [Related]
28. Streamlining the assessment of haematuria: 3-year outcomes of a dedicated haematuria clinic.
Sapre N; Hayes E; Bugeja P; Corcoran NM; Costello AJ; Anderson PD
ANZ J Surg; 2015 May; 85(5):334-8. PubMed ID: 24989960
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of urologic malignancies in patients with asymptomatic dipstick hematuria: prospective study with 13 years' follow-up.
Mishriki SF; Nabi G; Cohen NP
Urology; 2008 Jan; 71(1):13-6. PubMed ID: 18242356
[TBL] [Abstract][Full Text] [Related]
30. Non-visible asymptomatic haematuria: a review of the guidelines from the urologist's perspective.
Sountoulides P; Mykoniatis I; Metaxa L
Expert Rev Anticancer Ther; 2017 Mar; 17(3):203-216. PubMed ID: 28116915
[TBL] [Abstract][Full Text] [Related]
31. Practical use of investigations in patients with hematuria.
El-Galley R; Abo-Kamil R; Burns JR; Phillips J; Kolettis PN
J Endourol; 2008 Jan; 22(1):51-6. PubMed ID: 18315474
[TBL] [Abstract][Full Text] [Related]
32. The '2-week wait' rule for referrals for suspected urological cancers--urgent need for refinement of criteria.
Hawary AM; Warburton HE; Brough RJ; Collins GN; Brown SC; O'Reilly PH; Adeyoju AA
Ann R Coll Surg Engl; 2008 Sep; 90(6):517-22. PubMed ID: 18765032
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
Sagnak L; Ersoy H; Gucuk O; Ozok U; Topaloglu H
Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
[TBL] [Abstract][Full Text] [Related]
34. Haematuria work-up in general care-A German observational study.
Eisenhardt A; Heinemann D; Rübben H; Heß J
Int J Clin Pract; 2017 Aug; 71(8):. PubMed ID: 28750476
[TBL] [Abstract][Full Text] [Related]
35. The Harms of Hematuria Evaluation: Modeling the Risk-Benefit of Using Split Bolus Computerized Tomography Urography to Reduce Radiation Exposure in a Theoretical Cohort.
Dallmer JR; Robles J; Wile GE; Koyama T; Barocas DA
J Urol; 2019 Nov; 202(5):899-904. PubMed ID: 31188730
[TBL] [Abstract][Full Text] [Related]
36. Incidence of recurrent frank hematuria and urological cancers: prospective 6.9 years of followup.
Mishriki SF; Grimsley SJ; Nabi G
J Urol; 2009 Oct; 182(4):1294-8. PubMed ID: 19683300
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic evaluation of patients presenting with hematuria: An electronic health record-based study.
Richards KA; Ruiz VL; Murphy DR; Downs TM; Abel EJ; Jarrard DF; Singh H
Urol Oncol; 2018 Mar; 36(3):88.e19-88.e25. PubMed ID: 29169843
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
39. Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care.
Price SJ; Shephard EA; Stapley SA; Barraclough K; Hamilton WT
Br J Gen Pract; 2014 Sep; 64(626):e584-9. PubMed ID: 25179073
[TBL] [Abstract][Full Text] [Related]
40. Hematuria.
Peterson LM; Reed HS
Prim Care; 2019 Jun; 46(2):265-273. PubMed ID: 31030828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
